Local application of THIO-TEPA in the prevention of recurrent papillary carcinoma of the bladder

M. Csellár1, Á. Csontai1
1Department of Urology, Semmelweis University Medical School, Budapest

Tóm tắt

Prophylactic local THIO-TEPA treatment was employed in 44 cases over a period of five years, following radical surgery (including reoperations) for recurrent vesical papillomatosis or carcinoma, and numerous subsequent transurethral coagulations or resections owing to multiple recurrences. Three patients have been now free from recurrences for five years, 13 patients for four years, 11 patients for three years and 9 patients for two years. Eight patients proved unresponsive, the recurrence rate having remained unaffected. No toxic effects requiring any special measures were encountered.

Từ khóa


Tài liệu tham khảo

Abbasian, A., Wallace, D. D.: Intracavitary chemotherapy of diffuse, non-infiltrating papillary carcinoma of the bladder.J. Urol., 96, 461 (1966). Bateman, J. C.: Chemotherapy of solid tumours with triethylene thiophosphoramide.New Engl. J. Med., 252, 879 (1955). Bruce, D. W., Edgcomb, J. H.: Panycytopenia and generalized sepsis following treatment of cancer of the bladder with instillations of triethylene thiophosphoramide.J. Urol., 97, 482 (1967). Burnand, K. G., Boyd, P. J. R., Mayo, M. E., Shuttleworth, K. E. D., Lloyd-Davies, R. W.: Single dose intravesical Thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder carcinoma.Brit. J. Urol., 48, 55 (1976). Hisazumi, H., Uchibayashi, T., Naito, K., Misaki, T., Miyazaki, K.: Prophylactic use of Thio-tepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report.J. Urol., 114, 394 (1975). Jones, H. C., Swinney, J.: Thio-tepa in the treatment of tumours of the bladder.Lancet, II, 615 (1961). Lunglmayr, G., Kellner, G., Czech, K.: Austestung der Wirksamkeit von Thio-Tepa auf das Tumorgewebe bei der lokalen Chemotherapie der Blasenpapillomatose.Urol. Int., 25, 493 (1970). Lunglmayr, G., Czech, K.: Absorption studies on intraluminal Thio-Tepa for topical cytostatic treatment of low-stage bladder tumours.J. Urol., 106, 72 (1971). Melicow, M. M.: Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy.J. Urol., 68, 261 (1952). Mostofi, F. K.: A study of 2678 patients with initial carcinoma of the bladder.J. Urol., 75, 480 (1956). Pavone-Macaluso, M., Caramia, G., Rizzo, P. P.: The use of chemotherapeutic agents in the prophylaxis of papillary bladder tumours.Urol. Int., 26, 379 (1971). Veenema, R. J., Dean, A. L. Jr., Uson, A. C., Roberts, M., Longo, F.: Thio-Tepa bladder instillations: therapy and prophylaxis for superficial bladder tumours.J. Urol., 101, 811 (1969). Watkins, W. E., Kozak, J. A., Flanagan, M. J.: Severe pancytopenia associated with the use of intravesical Thio-Tepa.J. Urol., 98, 470 (1967). Wescott, J. W.: The prophylactic use of Thio-Tepa in transitional cell carcinoma of the bladder.J. Urol., 96, 913 (1966). Zingg, E., Rutishauser, G.: Unsere bisherigen Erfahrungen mit Thio-TEPA in Therapie und Prophylaxe der Blasenpapillome.Helv Chir. Acta, 34, 353 (1967).